Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral hetero...
Auteurs principaux: | Weitsman, G, Mitchell, NJ, Evans, R, Cheung, A, Kalber, TL, Bofinger, R, Fruhwirth, GO, Keppler, M, Wright, ZVF, Barber, PR, Gordon, P, de Koning, T, Wulaningsih, W, Vojnovic, B, Ameer-Beg, S, Lythgoe, M, Arnold, JN, Årstad, E, Festy, F, Hailes, HC, Tabor, AB, Ng, T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2018
|
Documents similaires
-
Near-infrared light-sensitive liposomes for enhanced plasmid DNA transfection
par: Wiraja, Christian, et autres
Publié: (2021) -
Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.
par: Graham, S, et autres
Publié: (2014) -
Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM
par: Coban, O, et autres
Publié: (2015) -
ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation
par: Monypenny, J, et autres
Publié: (2018) -
Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
par: Thomas, E, et autres
Publié: (2019)